- We will send in 10–14 business days.
/images/books/3577980/9780470096048.jpg)
- Author: Semizarov
- Publisher: John Wiley & Sons
- ISBN-10: 0470096047
- ISBN-13: 9780470096048
- Format: 15.5 x 23.6 x 2.8 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 17d.11:45:56
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Semizarov
- Publisher: John Wiley & Sons
- ISBN-10: 0470096047
- ISBN-13: 9780470096048
- Format: 15.5 x 23.6 x 2.8 cm, hardcover
- Language: English English
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.
Reviews